Get Started

CTNM

NASD Contineum Therapeutics, Inc. Class A
Nov 1, 2026 · 8:38 PM ET EOD Market Closed

$9.39 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.39, $0.19 below the day’s high of $9.58

YTD change
-17.85%
vs 20-day SMA
-3.42%
vs 200-day SMA
-30.78%

Price ranges

Previous day
$8.93 $9.58
open $9.14 close $9.39
+$0.25 (+2.74%)
Today
$8.93 $9.58
$9.39
Past week
$8.01 $9.87
from $8.40 now $9.39
+$1.00 (+11.85%)
Past month
$6.73 $13.86
from $12.99 now $9.39
-$3.60 (-27.71%)
This year
$6.73 $17.79
from $11.43 now $9.39
-$2.04 (-17.85%)

Price & Performance

-3.81 (-28.86%) / 6M

$6.24$10.30$14.35$18.41May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 57.3% away from all-time highs of $22.00
  • CTNM is down 18% since the beginning of the year
  • CTNM is down 11% over the past 12 months
  • CTNM is down 28% over the past 1 month
  • 9% of all CTNM investors are betting against CTNM

CTNM reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -11.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.4
Earnings momentum +11.8% Quarterly EPS growth
Quarterly change +11.8%

Valuation

P/E ratio N/A
Enterprise value $119.6M
Beta 0.86

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$236.6M
Debt$6.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $353.3M

Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.54 +3.19%
JNJ Johnson & Johnson $273.20 -0.73%
ABBV AbbVie, Inc. $294.89 +1.41%
MRK Merck & Co., Inc. $149.52 +2.18%
RHHBY Roche Holding Ltd Sponsored ADR $61.27 +0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.